Introduction:Basic information about CAS 205171-04-6|6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine |
|---|
| CAS Number | 205171-04-6 | Molecular Weight | 613.02 |
|---|
| Density | 1.41 | Boiling Point | 757.022ºC at 760 mmHg |
|---|
| Molecular Formula | C32H25ClN4O7 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purine |
|---|
| Synonym | More Synonyms |
|---|
BiologicalActivity
| Description | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine dibenzoate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|
| Related Catalog | Research Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>Nucleoside Antimetabolite/Analog |
|---|
| References | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
|---|
Chemical & Physical Properties
| Density | 1.41 |
|---|
| Boiling Point | 757.022ºC at 760 mmHg |
|---|
| Molecular Formula | C32H25ClN4O7 |
|---|
| Molecular Weight | 613.02 |
|---|
| Exact Mass | 612.14100 |
|---|
| PSA | 131.73000 |
|---|
| LogP | 5.07540 |
|---|
| Vapour Pressure | 0mmHg at 25°C |
|---|
| Index of Refraction | 1.667 |
|---|
| InChIKey | LSZDBTSFULCQHJ-KHWZNAFNSA-N |
|---|
| SMILES | CC1(OC(=O)c2ccccc2)C(OC(=O)c2ccccc2)C(COC(=O)c2ccccc2)OC1n1cnc2c(Cl)ncnc21 |
|---|
Synonyms
| (2R,3R,4R,5R)-5-[(benzoyloxy)methyl]-2-(6-chloro-9H-purin-9-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate |